Extraocular muscle susceptibility to myasthenia gravis: unique immunological environment?

作者: Jindrich Soltys , Bendi Gong , Henry J. Kaminski , Yuefang Zhou , Linda L. Kusner

DOI: 10.1196/ANNALS.1405.037

关键词:

摘要: Extraocular muscle (EOM) is susceptible to neuromuscular junction disorders, in particular, myasthenia gravis (MG). While EOM physiological characteristics and the ocular motor system requirements contribute propensity of deficits observed among patients with MG, authors propose that have immunological features place muscles at risk for immune attack. Genomic profiling studies demonstrated genes associated response are differentially expressed EOM, particular differences both classical alternative complement-mediated pathways. Intrinsic complement regulators lower levels rodent junctions, which would put them injury occurs MG. In fact, systemic C inhibition experimental autoimmune MG (EAMG) induced by administration acetylcholine receptor (AChR) antibodies or immunization AChR will eliminate deposition junctions other skeletal muscle, but not EOM. Also, greater active passive EAMG several measures, suggesting lack puts risk. Among patients, serum antibody low, support concept more than junctions. These observations suggest inhibitory therapies may prove be particularly effective treatment myasthenia.

参考文章(48)
Jörg Köhl, Self, Non-Self, and Danger: A Complementary View Advances in Experimental Medicine and Biology. ,vol. 586, pp. 71- 94 ,(2006) , 10.1007/0-387-34134-X_6
Mark J. Walport, Complement. First of two parts. The New England Journal of Medicine. ,vol. 344, pp. 1058- 1066 ,(2001) , 10.1056/NEJM200104053441406
Henry J. Kaminski, Robert L. Ruff, The Myasthenic Syndromes Springer, Boston, MA. pp. 565- 593 ,(1996) , 10.1007/978-1-4613-1143-0_28
Paul Travers, Charles A Janeway, Mark Walport, Mark J Shlomchik, The Immune System in Health and Disease Garland Science. ,(2001)
N Okada, H Okada, R Harada, T Fujita, Purification of 1F5 antigen that prevents complement attack on homologous cell membranes. Journal of Immunology. ,vol. 144, pp. 1823- 1828 ,(1990)
C M Gomez, G Biesecker, Inhibition of acute passive transfer experimental autoimmune myasthenia gravis with Fab antibody to complement C6. Journal of Immunology. ,vol. 142, pp. 2654- 2659 ,(1989)
John D. Porter, Georgiana Cheng, Transcriptional profile of rat extraocular muscle by serial analysis of gene expression. Investigative Ophthalmology & Visual Science. ,vol. 43, pp. 1048- 1058 ,(2002)
Premkumar Christadoss, C5 gene influences the development of murine myasthenia gravis. Journal of Immunology. ,vol. 140, pp. 2589- 2592 ,(1988)
Erdem Tüzün, Benjamin G. Scott, Elzbieta Goluszko, Stephen Higgs, Premkumar Christadoss, Genetic evidence for involvement of classical complement pathway in induction of experimental autoimmune myasthenia gravis Journal of Immunology. ,vol. 171, pp. 3847- 3854 ,(2003) , 10.4049/JIMMUNOL.171.7.3847
FRANK M. HOWARD, VANDA A. LENNON, JON FINLEY, JOSEPH MATSUMOTO, LILA R. ELVEBACK, Clinical correlations of antibodies that bind, block, or modulate human acetylcholine receptors in myasthenia gravis. Annals of the New York Academy of Sciences. ,vol. 505, pp. 526- 538 ,(1987) , 10.1111/J.1749-6632.1987.TB51321.X